SCHEMBL6183048

SCHEMBL6183048

CC(C)(C)OC(=O)N1CCC(N2CCC[C@@H](C(=O)N3CCOCC3)C2)CC1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.70
USP2 O75604 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HPGD P15428 1/20 0.55
ACACB O00763 1/20 0.52
ACACA Q13085 1/20 0.52
MAPK1 P28482 1/20 0.49
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.45
HSD17B10 Q99714 1/20 0.44
ADRA1A P35348 2/20 0.43
PIK3CA P42336 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
USP30 Q70CQ3 1/20 0.42
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182611 0.92 RECQL (0.64) RECQLUSP2SMN1; SMN2HPGDACACB
SCHEMBL6182618 0.92 RECQL (0.64) RECQLUSP2SMN1; SMN2HPGDACACB
SCHEMBL16238837 0.86 RECQL (0.71) RECQLUSP2SMN1; SMN2HPGDMAPK1
SCHEMBL7941694 0.86 RECQL (0.71) RECQLUSP2SMN1; SMN2HPGDMAPK1
SCHEMBL23471360 0.84 RECQL (0.67) RECQLUSP2SMN1; SMN2HPGDLMNA
SCHEMBL20116984 0.83 RECQL (1.00) RECQLUSP2SMN1; SMN2HPGDLMNA
SCHEMBL13575410 0.83 HPGD (0.50) RECQLSMN1; SMN2HPGDMEN1ALDH1A1
SCHEMBL3212775 0.82 USP2 (0.68) RECQLUSP2SMN1; SMN2HPGDLMNA
SCHEMBL4291742 0.81 HPGD (0.49) RECQLHPGDHSD17B10MEN1ALDH1A1
SCHEMBL16845137 0.81 HPGD (0.50) RECQLUSP2SMN1; SMN2HPGDADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 RECQL 2586/4885USP2 2198/4885SMN1; SMN2 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.